Evidence map›Paper›PMID 32613597›Full record

ArticleFamilial cancer2021

Report of the fifth meeting of the European Consortium 'Care for CMMRD' (C4CMMRD), Leiden, The Netherlands, July 6th 2019.

M Suerink, K Wimmer, L Brugieres, C Colas, R Gallon, T Ripperger, P R Benusiglio, E M A Bleiker, Z Ghorbanoghli, Y Goldberg and 7 more

Abstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in Familial cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

M SuerinkDepartment of Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands. m.suerink@lumc.nl.ORCID 0000-0001-7058-6973
K WimmerDivision of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.
L BrugieresChild and Adolescent Cancer Department, Gustave Roussy Cancer Campus, Villejuif, France.
C ColasDepartment of Genetics, Institut Curie, Université de Recherche Paris Sciences et Lettres, Paris, France.
R GallonFaculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
T RippergerDepartment of Human Genetics, Hannover Medical School, Hannover, Germany.
P R BenusiglioSorbonne Université, Inserm, Unité Mixte de Recherche Scientifique 938, Equipe Instabilité Des Microsatellites et Cancer Centre de Recherche Saint-Antoine, CRSA, Paris, France.
E M A BleikerDepartment of Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Z GhorbanoghliThe Netherlands Foundation for the Detection of Hereditary Tumours, Leiden, The Netherlands.
Y GoldbergRaphael Recanati Genetics Institute, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel.
J C H HardwickDepartment of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands.
M KloorDepartment of Applied Tumor Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
M le MentecDepartment of Genetics, Institut Curie, Université de Recherche Paris Sciences et Lettres, Paris, France.
M MulerisSorbonne Université, Inserm, Unité Mixte de Recherche Scientifique 938, Equipe Instabilité Des Microsatellites et Cancer Centre de Recherche Saint-Antoine, CRSA, Paris, France.
M PinedaHereditary Cancer Program, Catalan Institute of Oncology, ONCOBELL Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona, Catalonia, Spain.
C Ruiz-PonteFundacion Publica Galega de Medicina Xenomica, SERGAS, Instituto de Investigacion Sanitaria de Santiago (IDIS), Grupo de Medicina Xenomica-USC, Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), 15706, Santiago de Compostela, Spain.
H F A VasenDepartment of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands.

Funding

Cancer Research UK 24991
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Brain NeoplasmsColorectal NeoplasmsNeoplastic Syndromes, HereditaryAdolescentChildColonoscopyDiagnosis, DifferentialDNA Mismatch RepairDNA Polymerase IIDNA Polymerase IIIGenetic CounselingGerm-Line MutationGuidelines as TopicHumansImmune Checkpoint InhibitorsLi-Fraumeni SyndromeDNA Polymerase IIDNA Polymerase IIIImmune Checkpoint InhibitorsPOLD1 protein, humanPOLE protein, humanPoly-ADP-Ribose Binding Proteins

Identifiers

PMID32613597
PMCPMC7870763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.